Korsuva FDA Approval Status
FDA Approved: No
Brand name: Korsuva
Generic name: difelikefalin
Company: Cara Therapeutics, Inc.
Treatment for: Chronic Kidney Disease-Associated Pruritus
Korsuva (difelikefalin) is a selective peripheral kappa opioid receptor agonist in development for the treatment of moderate-to-severe pruritus in hemodialysis patients.
Development Timeline for Korsuva
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.